These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8347146)

  • 21. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
    Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
    Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of propranolol, pindolol, practolol and talinolol on arachidonic acid (AA)- and U-46619-induced aggregation and on AA-induced thromboxane A2 formation in platelets.
    Heinroth I; Block HU; Pönicke K; Förster W
    Prostaglandins Leukot Med; 1983 Oct; 12(2):189-206. PubMed ID: 6139824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle.
    Saussy DL; Mais DE; Knapp DR; Halushka PV
    Circulation; 1985 Dec; 72(6):1202-7. PubMed ID: 2998641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
    Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
    Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans.
    Nelson GJ; Schmidt PS; Bartolini GL; Kelley DS; Kyle D
    Lipids; 1997 Nov; 32(11):1129-36. PubMed ID: 9397397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
    Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
    Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
    J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of n-3 fatty acid supplementation on bleeding time, plasma fatty acid composition, and in vitro platelet aggregation in cats.
    Bright JM; Sullivan PS; Melton SL; Schneider JF; McDonald TP
    J Vet Intern Med; 1994; 8(4):247-52. PubMed ID: 7983618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epoxygenase metabolites of docosahexaenoic and eicosapentaenoic acids inhibit platelet aggregation at concentrations below those affecting thromboxane synthesis.
    VanRollins M
    J Pharmacol Exp Ther; 1995 Aug; 274(2):798-804. PubMed ID: 7636743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the influence on plasma lipids and platelet function of supplements of omega 3 and omega 6 polyunsaturated fatty acids.
    Sanders TA; Hochland MC
    Br J Nutr; 1983 Nov; 50(3):521-9. PubMed ID: 6639916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of thromboxane receptor activation in human platelets.
    Murray R; FitzGerald GA
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):124-8. PubMed ID: 2521385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets.
    di Minno G; Bertelé V; Bianchi L; Barbieri B; Cerletti C; Dejana E; de Gaetano G; Silver MJ
    Thromb Haemost; 1981 Apr; 45(2):103-6. PubMed ID: 6266066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man.
    Gresele P; Deckmyn H; Arnout J; Lemmens J; Janssens W; Vermylen J
    Lancet; 1984 May; 1(8384):991-4. PubMed ID: 6143969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Okwu AK; Ullian ME; Halushka PV
    J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty acids in human platelets and plasma. Fish oils decrease sensitivity toward N2 microbubbles.
    Bakken AM; Farstad M; Holmsen H
    J Appl Physiol (1985); 1991 Jun; 70(6):2669-72. PubMed ID: 1832147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
    Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
    [No Abstract]   [Full Text] [Related]  

  • 40. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N; Mais DE; Halushka PV
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.